High hepatic and extrahepatic mortality and low treatment uptake in HCV-coinfected persons in the Swiss HIV cohort study between 2001 and 2013
- 30 April 2015
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 63 (3), 573-580
- https://doi.org/10.1016/j.jhep.2015.04.019
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Barriers to Hepatitis C Antiviral Therapy in HIV/HCV Co-Infected Patients in the United States: A ReviewAIDS Patient Care and STDs, 2014
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infectionJournal of Hepatology, 2014
- Relationship of Liver Disease Stage and Antiviral Therapy With Liver-Related Events and Death in Adults Coinfected With HIV/HCVJama-Journal Of The American Medical Association, 2012
- Hepatitis C: The End of the Beginning and Possibly the Beginning of the EndAnnals of Internal Medicine, 2012
- A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis CClinical Gastroenterology and Hepatology, 2011
- Cohort Profile: The Swiss HIV Cohort StudyInternational Journal of Epidemiology, 2009
- Pegylated Interferon Alfa-2b vs Standard Interferon Alfa-2b, Plus Ribavirin, for Chronic Hepatitis C in HIV-Infected PatientsA Randomized Controlled TrialJama-Journal Of The American Medical Association, 2004
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected PatientsNew England Journal of Medicine, 2004
- Peginterferon Alfa-2a plus Ribavirin versus Interferon Alfa-2a plus Ribavirin for Chronic Hepatitis C in HIV-Coinfected PersonsNew England Journal of Medicine, 2004
- The Swiss HIV Cohort Study: Rationale, organization and selected baseline characteristicsInternational Journal of Public Health, 1994